Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
GMO
A GMO, or genetically modified organism, is a plant, animal, microorganism or other organism whose
genetic makeup has been modified in a laboratory using genetic engineering or transgenic technology.
This creates combinations of plant, animal, bacterial and virus genes that do not occur in nature or
through traditional crossbreeding methods. https://www.nongmoproject.org/gmo-facts/what-is-
gmo/
Genetic engineering
is the process of using recombinant DNA (rDNA) technology to alter the genetic makeup
of an organism. Traditionally, humans have manipulated genomes indirectly by
controlling breeding and selecting offspring with desired traits.
A transgenic, or genetically modified, organism is one that has been altered through
recombinant DNA technology, which involves either the combining of DNA from different genomes
or the insertion of foreign DNA into a genome.
DNA is the molecule that is the hereditary material in all living cells. Genes are made
of DNA, and so is the genome itself. A gene consists of enough DNA to code for one protein,
and a genome is simply the sum total of an organism's DNA.
POSITIVE
More nutritious food
Tastier food
Disease- and drought-resistant plants that require fewer environmental resources (such as water and
fertilizer)
Increased supply of food with reduced cost and longer shelf life
Food with more desirable traits, such as potatoes that produce less of a cancer-causing substance when
fried
Manufacturers use genetic modification to give foods desirable traits. For example, they have designed two new
Crop protection is the main rationale behind this type of genetic modification. Plants that are more resistant to
diseases spread by insects or viruses result in higher yields for farmers and a more attractive product.
All of these factors contribute to lower costs for the consumer. They can also ensure that more people have access
Getting published in your hometown paper is always a feather in your cap, and having grown
up on a farm about 30 miles outside of Buffalo, NY, having a guest column in the Buffalo
News is definitely a highlight.
In a new op ed I wrote for the Buffalo News, I note that GMOs, or genetically modified
organisms, are not only a lot less scary than pop culture would lead you to believe — they are
one of the most overlooked solutions to combating threats to our planet.
Genes moving from one GM plant or animal to another plant or animal that is not genetically
engineered
These concerns have proven to be unfounded. None of the GE foods used today have caused any
of these problems. The US Food and Drug Administration (FDA) assesses all GE foods to make
sure they are safe before allowing them to be sold. In addition to the FDA, the US Environmental
Protection Agency (EPA) and the US Department of Agriculture (USDA) regulate bioengineered
plants and animals. They assess the safety of GE foods to humans, animals, plants, and the
environment. (https://medlineplus.gov/ency/article/002432.htm#:~:text=The%20possible%20benefits
%20of%20genetic,such%20as%20water%20and%20fertilizer))
There are many purported downsides, but the evidence varies, and the main
health issues associated with GMO foods are hotly debated. Research is
ongoing.
This section discusses the evidence for a range of drawbacks that people
often associate with GMO foods.
Allergic reactions
Some people believe that GMO foods have more potential to trigger allergic
reactions. This is because they may contain genes from an allergen — a food
that prompts an allergic reaction.
The World Health Organization (WHO) discourage genetic engineers from
using DNA from allergens unless they can prove that the gene itself does not
cause the problem.
It is worth noting that there have been no reports of allergic effects of any
GMO foods currently on the market.
Cancer
Some researchers believe that eating GMO foods can contribute to the
development of cancer. They argue that because the disease is caused by
mutations in DNA, it is dangerous to introduce new genes into the body.
Antibacterial resistance
There is a small chance that the genes in food can transfer to cells the body
or bacteria in the gut. Some GMO plants contain genes that make them
resistant to certain antibiotics. This resistance could pass on to humans.
Outcrossing
Outcrossing refers to the risk of genes from certain GMO plants mixing with
those of conventional crops.
There have been reports of low levels of GMO crops approved as animal feed
or for industrial use being found in food meant for human consumption.
Medically reviewed by Debra Rose Wilson, Ph.D., MSN, R.N., IBCLC, AHN-
BC, CHT — Written by Amanda Barrell on February 27, 2019
The issue of genetically modified organisms (GMOs) as they relate to the food
supply is an ongoing, nuanced and highly contentious issue.
Individuals from the scientific and medical fields fall on both sides of the
argument, some claiming that genetically modified crops are helping to solve
issues concerning hunger, environmental sustainability and an increasing
global population, while others believe they’re doing more harm than good.
With studies supporting both sides, many wonder: Who should we believe? To
give a clearer sense of the issues and arguments that surround GMOs, Dr.
Sarah Evanega, a plant biologist, and Dr. David Perlmutter, a neurologist,
weigh in from opposing sides. Here’s what they had to say:
Genetic engineering is a tool that can help us breed crops that resist drought,
diseases, and insect pests, which means farmers achieve higher yields from
the crops they grow to feed their families and generate extra income. We have
seen, time and again, that farmers who grow GMO crops in Africa, and South
and East Asia earn extra money that helps them do things we Westerners
take for granted — like send their children to school and buy a propane stove
so they no longer have to cook over fires fueled by cow dung.
I know many of the scientists who are using genetic engineering to breed
improved crops, and I’ve witnessed their dedication to making the world a
better place. I support GMO food because I’ve seen first-hand how it can
improve people’s lives. For farmers, access to GMOs is a matter of social and
environmental justice.
DP:Without question, the various toxic herbicides that are liberally applied to
GM crops are having a devastating effect. In terms of the nutritional quality of
conventional versus GM food, it’s important to understand that mineral content
is, to a significant degree, dependent on the various soil-based
microorganisms. When the soil is treated with glyphosate, as is so often the
case with GM crops, it basically causes sterilization and deprives the plant of
its mineral absorption ability.
We’re also seeing the use of genetic engineering to breed crops that can
produce their own nitrogen, thrive in dry conditions, and resist pests. These
crops will directly benefit environmental healthby cutting the use of
fertilizers, pesticides, and water. Other researchers are working to accelerate
the rate of photosynthesis, which means crops can reach maturity quicker,
thus improving yields, reducing the need to farm new land, and sparing that
land for conservation or other purposes.
Genetic engineering can also be used to reduce food waste and its associated
environmental impact. Examples include non-browning mushrooms, apples,
and potatoes, but could also be expanded to include more perishable fruits.
There’s also tremendous potential in regard to genetically engineered
animals, such as pigs that produce less phosphorus material.
Perhaps even more importantly, though, is that these chemicals are harming
the soil microbiome. We are just now beginning to recognize that the various
organisms living in the soil act to protect plants and make them more disease
resistant. Destroying these protective organisms with the use of these
chemicals weaken plants’ natural defense mechanisms and, therefore, will
require the use of even more pesticides and other chemicals.
We now recognize that plants, like animals, are not autonomous, but rather
exist in a symbiotic relationship with diverse microorganisms. Plants are vitally
dependent upon soil microbes for their health and disease resistance.
We can’t expect to meet these enormous challenges using the same old crop
breeding methods. Genetic engineering offers us one tool for increasing yields
and reducing agriculture’s environmental footprint. It’s not a silver bullet — but
it’s an important tool in the plant breeder’s toolbox because it allows us to
develop improved crops more quickly than we could through conventional
methods. It also helps us work with important food crops like bananas, which
are very difficult to improve through conventional breeding methods.
We certainly can feed more people by reducing food waste and improving
food distribution and storage systems worldwide. But we can’t afford to ignore
important tools like genetic engineering, which can do a lot to improve the
productivity and quality of both crops and livestock.
The social and environmental problems that we face today are unprecedented
in scale and scope. We must use all the tools available to address the
challenge of feeding the world while taking care of the environment. GMOs
can play a part.
DP: The argument that we need GMO food to feed the entire world population
is absurd. The reality of the situation is that GM crops have actually not
increased the yield of any major commercialized food source. In fact, soy
— the most widely grown genetically modified crop — is actually experiencing
reduced yields. The promise of increased yield potentials with GM crops is
one that we have not realized.
Organic crops also have an environmental cost because they’re generally less
productive and require more tilling than conventional and GM crops. They also
use fertilizers from animals, which consume feed and water and produce
methane gas in their waste. In some cases, take apples for example, the
“natural” pesticides that organic growers use are far more toxic to humans and
the environment than what conventional growers use.
In terms of plant breeding, some of the improvements that are possible with
genetic engineering simply couldn’t be accomplished through traditional
methods. Again, genetic engineering offers plant breeders an important tool
that can result in a healthy, eco-friendly approach to agriculture. There’s
simply no scientific reason to avoid this technology in producing food for the
world’s growing population.
The research that looks at how microbes benefit plants is consistent with
similar research relating microorganisms to human health. So another
alternative is to harness and take full advantage of the beneficial interaction
between microorganisms and plants to create a healthier and more productive
agricultural experience.
Dr. Sarah Evanega is a plant biologist who earned her doctorate degree from Cornell
University, where she also helped lead a global project to help protect the world’s wheat
from wheat stem rust. She’s currently the director of the Cornell Alliance for
Science, a global communications initiative that’s seeking to restore science to the
policies and discussions around genetically engineered crops.
So the stakes are high. By eliminating “bad” genes from sperm and egg cells—called the “germline”—
these tools have the potential to permanently wipe out diseases caused by single mutations in genes,
such as cystic fibrosis, Huntington’s disease, or Tay-Sachs.
At the same time, there is huge uncertainty about what could go wrong if seemingly troubling genes are
eliminated.
One of the key researchers in the field is Jennifer Doudna at the University of California, Berkeley. She
has been touted for a Nobel Prize for the development of CRISPR-Cas9, a highly precise copy-paste
genetic tool. In the build-up to the meeting, Doudna made her concerns clear in Nature:
“Human-germline editing for the purposes of creating genome-modified humans should not proceed at
this time, partly because of the unknown social consequences, but also because the technology and our
knowledge of the human genome are simply not ready to do so safely.”
Her sentiments were echoed in a report released before the meeting by the Center for Genetics and
Society. They believe that research in genetic tools must advance, but only through therapy for adults
(where genetic modifications are targeted at some cells in the body but not passed on to kids, such as in
curing a form of inherited blindness). The report continues:
“But using the same techniques to modify embryos in order to make permanent, irreversible changes to
future generations and to our common genetic heritage—the human germline, as it is known—is far
more problematic.”
Consider sickle-cell anemia, an occasionally fatal genetic disorder. Its genes, though clearly harmful,
have persisted and spread because, while having two copies of the sickle-cell gene causes anemia,
having just one copy happens to provide protection against malaria, one of the most deadly diseases in
human history. Had we not known about their benefits, eliminating sickle-cell genes would have proved
to be a bad idea.
More importantly, there is a worry that once you allow for designer
babies you go down a slippery slope. Emily Smith Beitiks, disability
researcher at the University of California, San Francisco, said recently:
But the history of science shows that it is hard to keep such a cat in the
bag. Once developed, technologies have a way of finding their way into
the hands of those who desire to use them. That worries George
Church, a geneticist at Harvard Medical School, who has been a strong
voice in this debate since the beginning. In Nature, he writes:
And many believe that the risks of gene-editing are not that high
anyway. Nathaniel Comfort, a historian of medicine at Johns Hopkins
University in Baltimore, writes in Aeon:
Sir, - There has been a lot of publicity about the wonders of genetic engineering and
cloning, with Polly, Dolly, etc heralded as scientific successes. However, little has
been said about the serious animal welfare problems associated with these
techniques. We do not see pictures of the many failures, or of the invasive surgical
procedures used to produce genetically-engineered animals.
In reality, animal genetic engineering is a hit and miss affair. Of the 50,000 to
100,000 genes which make up a farm animal, the purpose of only about 2 per cent is
known. Adding genes from other animals is like playing with a chemistry set that has
all the labels removed. Except that in animal genetic engineering, the experimental
material is living creatures which can suffer and feel pain when the experiments go
horribly wrong.
For example, although the cloned lambs Megan and Morag looked normal, in fact,
the majority of the cloned lambs in that series of experiments had malformed
internal organs. In the experiments reported in February 1997 which produced the
cloned sheep, Dolly, 148 out of 156 implanted embryos failed to survive. In the
experiments which produced Polly, another cloned sheep, of the 14 foetuses alive at
60 days of pregnancy, only five developed into lambs which survived for more than
two weeks after birth. Some lambs were stillborn, and one had a heart defect and
was killed at two weeks old.
The problems are not confined to sheep. In 1994, reports emerged of a calf which
was given genetic material usually found in a chicken. At eight weeks old, the calf
seemed all right, but at 15 weeks the animal was no longer able to stand up and was
destroyed. The calf's muscle development had completely broken down. Genetically-
engineered salmon with added "anti-freeze" genes were coloured green and died of
gill and cranial deformities. And pigs which had added cow or human genes in an
effort to make them grow quicker suffered lameness, ulcers, damaged vision and
heart and kidney ailments.
People might be quite shocked to see the unnatural methods used to produce a
genetically-engineered animal or clones. This often involves invasive surgery and the
sacrifice of temporary "foster mothers". The usual technique used to clone animals is
as follows. Sheep that are to be egg donors are given hormone injections. The eggs
are then removed by surgery. After these eggs are cloned, it is common for the
cloned embryos to be placed into a temporary recipient sheep using surgery. Later,
these temporary "foster mothers" are killed, and the embryos are removed and
examined. They are then placed into a surrogate mother, again using surgery.
Clearly, cloning an animal is far from a natural process.
Compassion in World Farming is campaigning for a moratorium on animal genetic
engineering until there has been full public debate, and until the animal welfare
problems have been addressed and the ethical implications of creating artificial
animals has been fully explored. - Yours, etc., Mary-Anne Bartlett
Sir, - There has been a lot of publicity about the wonders of genetic engineering and
cloning, with Polly, Dolly, etc heralded as scientific successes. However, little has
been said about the serious animal welfare problems associated with these
techniques. We do not see pictures of the many failures, or of the invasive surgical
procedures used to produce genetically-engineered animals.
In reality, animal genetic engineering is a hit and miss affair. Of the 50,000 to
100,000 genes which make up a farm animal, the purpose of only about 2 per cent is
known. Adding genes from other animals is like playing with a chemistry set that has
all the labels removed. Except that in animal genetic engineering, the experimental
material is living creatures which can suffer and feel pain when the experiments go
horribly wrong.
For example, although the cloned lambs Megan and Morag looked normal, in fact,
the majority of the cloned lambs in that series of experiments had malformed
internal organs. In the experiments reported in February 1997 which produced the
cloned sheep, Dolly, 148 out of 156 implanted embryos failed to survive. In the
experiments which produced Polly, another cloned sheep, of the 14 foetuses alive at
60 days of pregnancy, only five developed into lambs which survived for more than
two weeks after birth. Some lambs were stillborn, and one had a heart defect and
was killed at two weeks old.
The problems are not confined to sheep. In 1994, reports emerged of a calf which
was given genetic material usually found in a chicken. At eight weeks old, the calf
seemed all right, but at 15 weeks the animal was no longer able to stand up and was
destroyed. The calf's muscle development had completely broken down. Genetically-
engineered salmon with added "anti-freeze" genes were coloured green and died of
gill and cranial deformities. And pigs which had added cow or human genes in an
effort to make them grow quicker suffered lameness, ulcers, damaged vision and
heart and kidney ailments.
People might be quite shocked to see the unnatural methods used to produce a
genetically-engineered animal or clones. This often involves invasive surgery and the
sacrifice of temporary "foster mothers". The usual technique used to clone animals is
as follows. Sheep that are to be egg donors are given hormone injections. The eggs
are then removed by surgery. After these eggs are cloned, it is common for the
cloned embryos to be placed into a temporary recipient sheep using surgery. Later,
these temporary "foster mothers" are killed, and the embryos are removed and
examined. They are then placed into a surrogate mother, again using surgery.
Clearly, cloning an animal is far from a natural process.
Compassion in World Farming is campaigning for a moratorium on animal genetic
engineering until there has been full public debate, and until the animal welfare
problems have been addressed and the ethical implications of creating artificial
animals has been fully explored. - Yours, etc., Mary-Anne Bartlett
https://www.irishtimes.com/opinion/letters/failures-in-genetic-
engineering-1.139384
Each new genetic test that is developed raises serious issues for medicine, public health, and
social policy regarding the circumstances under which the test should be used, how the test is
implemented, and what uses are made of its results. Should people be allowed to choose or
refuse the test, or should it be mandatory, as newborn screening is in some states? Should people
be able to control access to the results of their tests? If test results are released to third parties
such as employers or insurers, what protections should be in place to ensure that people are not
treated unfairly because of their genotype?
The answers to these questions depend in part on the significance given to four important ethical
and legal principles: autonomy, confidentiality, privacy, and equity. A review of the meaning of
those concepts and how they are currently protected by the law provides a starting point for the
development of recommendations on the degree of control people should have in deciding
whether to undergo genetic testing and what uses should be made of the results. The task is a
pressing one. In a 1992 national probability survey of the public, sponsored by the March of
Dimes, 38 percent of respondents said that new types of genetic testing should be stopped
altogether until the privacy issues are settled.1
This chapter reviews some of the conflicts that will arise in the research and clinical settings, and
suggests general principles that should be the starting point for policy analyses in this evolving
field.
Since many of the references in this chapter are legal citations, its references appear in legal style
as numbered end notes.
Go to:
KEY DEFINITIONS
Autonomy
Ethical Analysis
Autonomy can be defined as self-determination, self-rule, or self-governance. Autonomous
agents or actions presuppose some capacity of reasoning, deciding, and willing. Moral, social,
and legal norms establish obligations to respect autonomous agents and their choices. Respect for
personal autonomy implies that agents have the right or power to be self-governing and self-
directing, without outside control. In the context of genetic testing and screening, respect for
autonomy refers to the right of persons to make an informed, independent judgment about
whether they wish to be tested and then whether they wish to know the details of the outcome of
the testing. Autonomy is also the right of the individual to control his or her destiny, with or
without reliance on genetic information, and to avoid interference by others with important life
decisions, whether these are based on genetic information or other factors. Respect for autonomy
also implies the right of persons to control the future use of genetic material submitted for
analysis for a specific purpose (including when the genetic material itself and the information
derived from that material may be stored for future analysis, such as in a DNA bank or registry
file).
Even though respect for autonomy is centrally important in our society, it is not absolute. It can
be overridden in some circumstances, for example, to prevent serious harm to others, as is the
case in mandatory newborn screening for phenylketonuria (PKU) and hypothyroidism.
Legal Issues
The legal concept of autonomy serves as the basis for numerous decisions protecting a person's
bodily integrity. In particular, cases have held that competent adults have the right to choose
whether or not to undergo medical interventions.2 Before people make such a choice, they have a
right to be informed of facts that might be material to their decision,3 such as the nature of their
condition and its prognosis,4 the potential risks and benefits of a proposed test or treatment,5 and
the alternatives to the proposed intervention.6 In the genetics context, health care providers have
been held liable for not providing the information that a genetic test is available. 7
People also have a right to be informed about and to control the subsequent use of tissue that has
been removed from their bodies. 8 There is some leeway under the federal regulations governing
research involving human subjects for researchers to undertake subsequent research on blood
samples provided for genetic tests (as in the newborn screening context) as long as the samples
are anonymous and as long as the subsequent use was not anticipated at the time the sample was
collected.9 If the additional test was anticipated at the time the sample was collected, informed
consent for that use should be obtained prior to the collection of the original sample.
Such an approach is thought appropriate to avert conflicts of interest, such as a
physician/researcher suggesting that a patient undergo a particular test when the researcher
actually wanted the tissue for the researcher's own additional use in a research or commercial
project. In such a situation, the patient's autonomy is compromised even if the sample is used
anonymously in the subsequent use. A report from the Office of Technology Assessment
similarly stressed the importance of knowledge and consent:
The consent of the patient is required to remove blood or tissue from his or her body, and also to
perform tests, but it is important that the patient be informed of all the tests which are done and
that a concern for the privacy of the patient extends to the control of tissues removed from his or
her body. 10
Privacy
Ethical Analysis
Among the various definitions of privacy, one broad definition captures its central element:
privacy is "a state or condition of limited access to a person."11 People have privacy if others lack
or do not exercise access to them. They have privacy if they are left alone and do not suffer
unauthorized intrusion by others. Once persons undergo genetic tests, privacy includes the right
to make an informed, independent decision about whether—and which—others may know
details of their genome (e.g., insurers, employers, educational institutions, spouses and other
family members, researchers, and social agencies).
Various justifications have been offered for rules of privacy. First, some philosophers argue that
privacy rights are merely shorthand expressions for a cluster of personal and property rights,
each of which can be explicated without any reference to the concept of privacy. In making this
argument, Judith Jarvis Thomson holds that privacy rights simply reflect personal and property
rights, such as the rights not to be looked at, not to be overheard, and not to be caused distress. 12
A second justification holds that rights to privacy are important instruments or means to other
goods, including intimate relations such as trust and friendship. Being able to control access to
themselves enables people to have various kinds of relationships with different people, rather
than being equally accessible to all others.
A third approach finds the basis for rights to privacy in respect for personal autonomy.
Decisional privacy is often very close to personal autonomy. The language of personal autonomy
reflects the idea of a domain or territory of self-rule, and thus overlaps with zones of decisional
privacy.
Whatever their rationale or justification, rights of privacy are the subject of ongoing debate about
their scope and weight. However, their scope is not unlimited, and they do not always override
all other competing interests, such as the interests of others.
Legal Issues
In the legal sphere, the principle of privacy is an umbrella concept encompassing issues of both
autonomy and confidentiality. The right to make choices about one's health care is protected, in
part, by the right to privacy guaranteed by the U.S. Constitution, as well as state constitutions.
This includes a right to make certain reproductive choices,13 such as whether to use genetic
testing.14 It also includes a right to refuse treatment.
An entirely different standard of privacy protects personal information. A few court decisions
find protection for such information under the constitutional doctrine of privacy,15 but more
commonly, privacy protection against disclosure of personal information is found under common
law tort principles.16 In addition, there is a federal privacy act,17 as well as state statutes protecting
privacy.
Confidentiality
Ethical Analysis
Confidentiality as a principle implies that some body of information is sensitive, and hence,
access to it must be controlled and limited to parties authorized to have such access. The
information provided within the relationship is given in confidence, with the expectation that it
will not be disclosed to others or will be disclosed to others only within limits. The state or
condition of nondisclosure or limited disclosure may be protected by moral, social, or legal
principles and rules, which can be expressed in terms of rights or obligations.
In health care and various other relationships, we grant others access to our bodies. They may
touch, observe, listen, palpate, and even physically invade. They may examine our bodies as a
whole or in parts; and parts, such as tissue, may be removed for further study, as in some forms
of testing. Privacy is necessarily diminished when others have such access to us; rules of
confidentiality authorize us to control and thus to limit further access to the information
generated in that relationship. For example, rules of confidentiality may prohibit a physician
from disclosing some information to an insurance company or an employer without the patient's
authorization.
Rules of confidentiality appear in virtually every code or set of regulations for health care
relationships. Their presence is not surprising, because such rules are often justified on the basis
of their instrumental value: if prospective patients cannot count on health care professionals to
maintain confidentiality, they will be reluctant to allow professionals the full and complete
access necessary for diagnosis and treatment. Hence, rules of confidentiality are indispensable
for patient and social welfare; without those rules, people who need medical, psychiatric, or
other treatment will refrain from seeking or fully participating in it. Another justification for
rules of confidentiality is based on the principles of respect for autonomy and privacy, above.
Respecting persons involves respecting their zone of privacy and accepting their decisions to
control access to information about them. When people grant health care professionals access to
them, they should retain the right to determine who else has access to the information generated
in that relationship. Hence, the arguments for respect for autonomy and privacy support rules of
confidentiality. Finally, duties of confidentiality often derive from explicit or implicit promises
in the relationship. For instance, if the professional's public oath or the profession's code of ethics
promises confidentiality of information, and the particular professional does not specifically
disavow it, then the patient has a right to expect that information generated in the relationship
will be treated as confidential.18
There are at least two distinct types of infringements of rules of confidentiality. On the one hand,
rules of confidentiality are sometimes infringed through deliberate breaches. On the other hand,
rules of confidentiality are often infringed through carelessness, for example, when health care
professionals do not take adequate precautions to protect the confidential information. Some
commentators argue that both carelessness and modern practices of health care have rendered
medical confidentiality a "decrepit concept," since it is compromised routinely in the provision
of health care.19
It is widely recognized that the rules of confidentiality are limited in at least two senses: (1) some
information may not be protected, and (2) the rules may sometimes be overridden to protect
other values. First, not all information is deemed confidential, and patients do not have a right to
expect that such information will be protected from disclosure to others. For example, laws
frequently require that health care professionals report gunshot wounds, venereal diseases, and
other communicable diseases such as tuberculosis. Second, health care professionals may also
have a moral or legal right (and sometimes even an obligation) to infringe rules of
confidentiality, for example, to prevent a serious harm from occurring. In such cases, rules of
confidentiality protect the information, but they can be overridden in order to protect some other
value. Judgments about such cases depend on the probability of serious harm occurring unless
confidentiality is breached. Any justified infringements of rules of confidentiality should satisfy
the conditions identified earlier in the discussion of justified infringements of the principle of
respect for autonomy.
Legal Issues
The legal concept of confidentiality focuses on the information that people provide to their
physicians. The protection of confidentiality is thought to serve an important public health goal
in encouraging people to seek access to health care. It is thought that the patient's interest can be
served only in an atmosphere of total frankness and candor. 20 Without the promise of
confidentiality, people might avoid seeking medical treatment, thus potentially harming
themselves as well as the community. In fact, the first doctor-patient confidentiality statute was
passed in 1828 in New York during the smallpox epidemic to encourage people to seek health
care. Various legal decisions have protected confidentiality of health care information,21 as have
certain state and federal statutes.
Confidentiality of health care information is also protected because disclosure of a person's
medical condition can cause harm to him or her. An alternative set of legal principles-those
penalizing discrimination (see below)-protects people against unfair uses of certain information.
Equity
Ethical Analysis
Issues of justice, fairness, and equity crop up in several actions, practices, and policies relating to
genetic testing. It is now commonplace to distinguish formal justice from substantive justice.
Formal justice requires treating similar cases in a similar way. Standards of substantive or
material justice establish the identity of the relevant similarities and differences and the
appropriate responses to those similarities and differences. For instance, a society has to
determine whether to distribute a scarce resource such as health care according to persons'
differences in need, social worth, or ability to pay.
One crucial question is whether genetic disorders or predispositions provide a basis for blocking
access to certain social goods, such as employment or health insurance. Most conceptions of
justice dictate that employment be based on the ability to perform particular tasks effectively and
safely. For these conceptions, it is unjust to deny employment to someone who meets the
relevant qualifications but also has a genetic disease. Frequently these questions of employment
overlap with questions of health insurance. Practices of medical underwriting in health insurance
reflect what is often called "actuarial fairness"-that is, grouping those with similar risks together
so insurers can accurately predict costs, and set fair and sufficient premium rates. Although
actuarial fairness may be intuitively appealing, critics argue that it does not express moral or
social fairness. According to Norman Daniels, there is "a clear mismatch between standard
underwriting practices and the social function of health insurance" in providing individuals with
resources for access to health care22 (see Chapter 7).
The fundamental argument for excluding genetic discrimination in health insurance amounts to
an argument for establishing a right to health care. One of the central issues in debates about the
distribution of health care is one's view of the "natural lottery," in particular, a "genetic
lottery."23 The metaphor of a lottery suggests that health needs result largely from an impersonal
natural lottery and are thus undeserved. But even if health needs are largely undeserved because
of the role of chance, society's response to those needs may vary, as H. Tristram Engelhardt
notes, depending on whether it views those needs as unfair or as unfortunate. 24 If health needs
are unfortunate, but not unfair, they may be the object of individual or social compassion. Other
individuals, voluntary associations, and even society may be motivated by compassion to try to
meet those needs. If, however, the needs are viewed as unfair as well as unfortunate, society may
have a duty of justice to try to meet those needs.
One prominent argument for the societal provision of a decent minimum of health care is that,
generally, health needs are randomly distributed and unpredictable, as well as overwhelming
when health crises occur. 25 Because of these features of health needs, many argue that it is
inappropriate to distribute health care according to merit, societal contribution, or even ability to
pay. Another version of the argument from fairness holds that health needs represent departures
from normal species functioning and deprive people of fair equality of opportunity. Thus,
fairness requires the provision of health care to "maintain, restore, or compensate for the loss of
normal functioning" in order to ensure fair equality of opportunity.26
Several committee members expressed concerns that these stated arguments are somewhat
weakened by the fact that a number of diseases are not the result of random events, but are
brought on or exacerbated by dispensable habits such as cigarette smoking and excessive alcohol
ingestion. While our and other societies attempt to discourage such habits by education and
taxation, there is general agreement that access to full health care must be ensured once illness
develops. If a tendency to abuse alcohol, for example, were to have a genetic predisposition, an
additional argument could be made for providing the same level of health care to everyone since
a person does not choose his or her genetic propensities.
The argument that society should guarantee or provide a decent minimum of health care for all
citizens and residents points toward a direction for health policy, but it does not determine
exactly how much health care the society should provide relative to other goods it also seeks.
And, within the health care budget, there will be difficult allocation questions, including how
much should be used for particular illnesses and for particular treatments for those illnesses.
Questions of allocation cannot be resolved in the abstract. In democratic societies, they should be
resolved through political processes that express the public's will. In specifying and
implementing a conception of a decent minimum, an adequate level, or a fair share of health care
in the context of scarce resources, as the President's Commission noted in 1983, it is reasonable
for a society to turn to fair, democratic political procedures to choose among alternative
conceptions of adequate health care, and in view of "the great imprecision in the notion of
adequate health care ... it is especially important that the procedures used to define that level be
—and be perceived to be—fair."27
Legal Issues
The concept of equity serves as the underpinning for a variety of legal doctrines and statutes.
Certain needy people are provided health care, including some genetics services, under
government programs such as Medicaid (see Chapter 7). In addition, some legislative efforts
have been made to prohibit discrimination based on genotype. For example, some states have
statutes prohibiting discrimination in employment based on one's genotype.28 And nearly all
people over age 65 are deemed to have a right to care (under Medicare).
https://www.ncbi.nlm.nih.gov/books/NBK236044/
Risks
Generally genetic tests have little physical risk. Blood and cheek swab tests have
almost no risk. However, prenatal testing such as amniocentesis or chorionic villus
sampling has a small risk of pregnancy loss (miscarriage).
Genetic testing can have emotional, social and financial risks as well. Discuss all risks
and benefits of genetic testing with your doctor, a medical geneticist or a genetic
counselor before you have a genetic test.
Before you have genetic testing, gather as much information as you can about your
family's medical history. Then, talk with your doctor or a genetic counselor about your
personal and family medical history to better understand your risk. Ask questions and
discuss any concerns about genetic testing at that meeting. Also, talk about your
options, depending on the test results.
If you're being tested for a genetic disorder that runs in families, you may want to
consider discussing your decision to have genetic testing with your family. Having these
conversations before testing can give you a sense of how your family might respond to
your test results and how it may affect them.
Not all health insurance policies pay for genetic testing. So, before you have a genetic
test, check with your insurance provider to see what will be covered.
In the United States, the federal Genetic Information Nondiscrimination Act of 2008
(GINA) helps prevent health insurers or employers from discriminating against you
based on test results. Under GINA, employment discrimination based on genetic risk
also is illegal. However, this act does not cover life, long-term care or disability
insurance. Most states offer additional protection.
Depending on the type of test, a sample of your blood, skin, amniotic fluid or other
tissue will be collected and sent to a lab for analysis.
Blood sample. A member of your health care team takes the sample by inserting a
needle into a vein in your arm. For newborn screening tests, a blood sample is taken by
pricking your baby's heel.
Cheek swab. For some tests, a swab sample from the inside of your cheek is collected
for genetic testing.
Amniocentesis. In this prenatal genetic test, your doctor inserts a thin, hollow needle
through your abdominal wall and into your uterus to collect a small amount of amniotic
fluid for testing.
Chorionic villus sampling. For this prenatal genetic test, your doctor takes a tissue
sample from the placenta. Depending on your situation, the sample may be taken with a
tube (catheter) through your cervix or through your abdominal wall and uterus using a thin
needle.
Results
The amount of time it takes for you to receive your genetic test results depends on the
type of test and your health care facility. Talk to your doctor, medical geneticist or
genetic counselor before the test about when you can expect the results and have a
discussion about them.
Positive results
If the genetic test result is positive, that means the genetic change that was being tested
for was detected. The steps you take after you receive a positive result will depend on
the reason you had genetic testing.
If the purpose is to:
Diagnose a specific disease or condition, a positive result will help you and your
doctor determine the right treatment and management plan.
Find out if you are carrying a gene that could cause disease in your child, and the
test is positive, your doctor, medical geneticist or a genetic counselor can help you
determine your child's risk of actually developing the disease. The test results can also
provide information to consider as you and your partner make family planning decisions.
Determine if you might develop a certain disease, a positive test doesn't necessarily
mean you'll get that disorder. For example, having a breast cancer gene
(BRCA1 or BRCA2) means you're at high risk of developing breast cancer at some point in
your life, but it doesn't indicate with certainty that you'll get breast cancer. However, with
some conditions, such as Huntington's disease, having the altered gene does indicate that
the disease will eventually develop.
Talk to your doctor about what a positive result means for you. In some cases, you can
make lifestyle changes that may reduce your risk of developing a disease, even if you
have a gene that makes you more susceptible to a disorder. Results may also help you
make choices related to treatment, family planning, careers and insurance coverage.
Negative results
A negative result means a mutated gene was not detected by the test, which can be
reassuring, but it's not a 100 percent guarantee that you don't have the disorder. The
accuracy of genetic tests to detect mutated genes varies, depending on the condition
being tested for and whether or not the gene mutation was previously identified in a
family member.
Even if you don't have the mutated gene, that doesn't necessarily mean you'll never get
the disease. For example, the majority of people who develop breast cancer don't have
a breast cancer gene (BRCA1 or BRCA2). Also, genetic testing may not be able to
detect all genetic defects.
Inconclusive results
In some cases, a genetic test may not provide helpful information about the gene in
question. Everyone has variations in the way genes appear, and often these variations
don't affect your health. But sometimes it can be difficult to distinguish between a
disease-causing gene and a harmless gene variation. These changes are called
variants of uncertain significance. In these situations, follow-up testing or periodic
reviews of the gene over time may be necessary.
Genetic counseling
No matter what the results of your genetic testing, talk with your doctor, medical
geneticist or genetic counselor about questions or concerns you may have. This will
help you understand what the results mean for you and your family.
Clinical trials
Explore Mayo Clinic studies testing new treatments, interventions and tests as a means
to prevent, detect, treat or manage this disease.
https://www.mayoclinic.org/tests-procedures/genetic-testing/about/pac-20384827#:~:text=Generally
%20genetic%20tests%20have%20little,and%20financial%20risks%20as%20well.
BIOTECHNOLOGY
Biotechnology is technology that utilizes biological systems, living organisms or
parts of this to develop or create different products.
Brewing and baking bread are examples of processes that fall within the concept of
biotechnology (use of yeast (= living organism) to produce the desired product). Such
traditional processes usually utilize the living organisms in their natural form (or further
developed by breeding), while the more modern form of biotechnology will generally
involve a more advanced modification of the biological system or organism.
https://www.ntnu.edu/ibt/about-us/what-is-biotechnology#:~:text=Biotechnology%20is
%20technology%20that%20utilizes,to%20produce%20the%20desired%20product).
A. Bioweapon
Biological weapons are microorganisms like virus, bacteria, fungi, or other toxins
that are produced and released deliberately to cause disease and death in
humans, animals or plants.
Biological agents, like anthrax, botulinum toxin and plague can pose a difficult
public health challenge causing large numbers of deaths in a short amount of
time while being difficult to contain. Bioterrorism attacks could also result in an
epidemic, for example if Ebola or Lassa viruses were used as the biological
agents.
Biological weapons is a subset of a larger class of weapons referred to
as weapons of mass destruction, which also includes chemical, nuclear and
radiological weapons. The use of biological agents is a serious problem, and the
risk of using these agents in a bioterrorist attack is increasing.
Disadvantages:
Hidden MSG
While monosodium glutamate (MSG) cannot be used on organic food, there
are several other free glutamic acid compounds that organic foods may
contain.
GMO foods are most commonly created to provide a higher nutritional value
to food and to also make it resistant to pests.
GMO crops lead to an increase in the use of chemical pesticides because the
crops have a higher tolerance to withstand these chemicals. This means our
environment and farming communities have more exposure to these
herbicides and pesticides which causes more pollution to the ocean and
air[*].
In fact, organic foods can cost up to 50% higher than regular foods[*].
Non-GMO has many similarities to the organic label but they aren't exactly
the same. This label means that the ingredients in any specific food product
have been verified by the Non-GMO project to ensure no genetically
modified material is present. For meat, this includes the food the animals ate
to ensure there are no GMOs in their bodies.
This is achieved by testing every ingredient that goes into the final product.
Companies and their suppliers with the non-GMO stamp of approval are
inspected yearly to make sure they are compliant with Non-GMO Project
standards.
The slight difference with the organic label is that non-GMO prevents the use
of herbicides that contain GMOs, but it does not mean it must be grown
organically. They could be grown with conventional, non-organic
approaches.
Bottom line: Organic and Non-GMO are similar in the fact that both labels
go through rigorous testing to ensure genetically modified material is not
present in the food or the creation of it.
Organic foods are the most heavily regulated label. Purchasing foods with
the "non-GMO" or "organic" label is your safest bet when it comes to
overall health and minimal toxins.
Organic and non-GMO labels are highly similar. In fact, many times the
only reason why certain companies don't take the extra step for the organic
label is that it cost farmers hundreds of thousands of dollars just to get the
certification. Whereas non-GMO is almost identical but cost much less for
verification.
Hidden MSG
While monosodium glutamate (MSG) cannot be used on organic food, there
are several other free glutamic acid compounds that organic foods may
contain.
Vegetable Oils
Vegetable oils including canola oil, corn oil, soybean oil, safflower oil, and
cottonseed oil are linked to increased inflammation and metabolic disease[*].
(https://chomps.com/blogs/news/gmo-vs-organic)
Microbes:
Is a microscopic organism, which may exist in its single-celled form or in a colony of cells.
a microorganism, especially a bacterium causing disease or fermentation.
Bioremediation is the use of organisms to metabolize pollutants. Instead of simply collecting the
pollutant and storing it, bioremediation relies on living organisms to consume and break down the
compound, turning it into harmless, natural substances. Bioremediators are any organism used for
bioremediation. Typically, microbes like bacteria, archaea and fungi are the prime bioremediators.
There are lots of different types, they grow very rapidly, and they can be easily modified genetically.
This doesn't mean plants and animals can't be used as bioremediators. It simply means that these
microbes are much easier to use and often better suited to the tasks at hand. In order to better
understand bioremediation, let's continue with the theme of oil spills.
Natural Bioremediators
Fortunately, microbes capable of breaking down nearly all of these compounds already exist. You
can bet as soon as that oil started appearing on Earth, bacteria and archaea evolved ways to exploit
it as an energy source. After countless billions of mutations and generations, a large, diverse
community of microbes evolved. Each species targets one or a select few of the molecules,
efficiently breaking them down, releasing energy.
Some species are able to take their compound down to carbon dioxide and water. Other species
simply break large molecules into smaller chunks that are in turn broken down by a different species.
The process is slow but nearly 100% effective. So, bioremediation is able to clean up these oil spills
but not in a time frame that is acceptable to most environmentalists. Who has time to wait 1,000
years for nature's garbage men to take care of business? It's time to introduce another term.
BIOTECHNOLOGY.
BANE
The Cons of Biotechnology
1. It creates an all-or-nothing approach.
One of the biggest problems that biotechnology faces is a lack of genetic
diversity. The processes included in this field can increase crop yields and
improve medical science, but it comes at the price of a genetic bottleneck.
Should something unforeseen happen, an entire crop or medical treatment
opportunity could go to waste or even threaten the survival of certain species.
2. It is a field of research with many unknowns.
Although our database of biotechnology has greatly expanded in the last
generation, there are still many long-term unknowns that we face. What
happens if we tinker with the genetics of a person to treat a disorder? What
happens to the environment if we dramatically alter crops to grow in locations
that would normally not support crop growth? Should every action have an
equal and opposite reaction, future generations could pay the price for our
research that is happening today.
3. It could ruin croplands.
Biotechnology has allowed more vitamins and minerals to enter our food
chain, but it could be coming at a cost. Many crops obtain their nutritional
content from the soil in which they grow. If that soil is overloaded by the crop,
it may lose its viability, even with crop rotation occurring. That may reduce the
amount of growing time each land segment is able to provide while extending
its recovery period at the same time. In some situations, the croplands could
be permanently ruined.
4. It turns human life into a commodity.
In the United States, the Supreme Court has ruled that DNA which is lab
manipulated is eligible to be patented. The foundation of this ruling was that
altered DNA sequences are not found in nature. At the moment,
complementary DNA, or cDNA, has been specifically mentioned as an
example of what could be patented. Obtaining DNA to create altered DNA
sequences for profit minimizes human life (or plant and animal life) to profit
potential. It also opens the door to ethical and moral questions, such as when
human life begins, with the purpose of maximizing the dollars and cents that
can be obtained.
5. It can be used for destruction.
All the benefits that biotechnology can provide could also be turned into a
weapon that is used for mass destruction. Crops can be improved, but they
can also be destroyed. Medicines can be made with biotechnology, but
diseases can also be weaponized. If left unchecked, biotechnology could even
create a societal class that is created specifically for research purposes only.
Biotechnology has done much to improve our way of life. It has helped the
world to become a much smaller place. At the same time, we still face many
challenges that must be overcome.
Bioethics concerns itself with addressing ethical issues in healthcare, medicine, research,
biotechnology, and the environment. Typically these issues are addressed from many different
disciplines. People contribute to the bioethics discussion drawing on expertise and methods from the
sciences, social sciences, and the humanities. Professionals working in the field of bioethics include
philosophers, scientists, health administrators, lawyers, theologians, anthropologists, disability
advocates, and social workers. People may teach, do research, treat patients in the clinical setting or
work to change laws or public policy. The issues of bioethics are at the intersection between
medicine, law, public policy, religion, and science. Each field contributes important insights,
resources and methodologies and efforts to think about or make changes to practices and policies
that raise ethical concerns are often strongest when they draw on resources across disciplines. The
Showcase submission formats include some commonly used formats to present bioethics-related
proposals or findings.
Examples of topic areas that have been the focus of bioethics for a long time are organ donation and
transplantation, genetic research, death and dying, and environmental concerns. New
developments in science and technology have focused attention on topics such as assisted
reproductive technologies, neuroethics (ethical issues around brain imaging and testing), and
nanotechnologies (using small particles to deliver medicine or other medical treatments).
Some disadvantages, or risks, that come from genetic testing can include:
Testing may increase anxiety and stress for some individuals
Testing does not eliminate a person’s risk for cancer
Results in some cases may return inconclusive or uncertain
Benefits
Direct-to-consumer genetic testing promotes awareness of genetic diseases.
It provides personalized information about your health, disease risk, and other
traits.
It may help you be more proactive about your health.
It does not require approval from a healthcare provider or health insurance
company.
It is often less expensive than genetic testing obtained through a healthcare
provider.
DNA sample collection is usually simple and noninvasive, and results are
available quickly.
Your data is added to a large database that can be used to further medical
research. Depending on the company, the database may represent up to several
million participants.
Direct-to-consumer genetic testing provides only partial information about your health.
Other genetic and environmental factors, lifestyle choices, and family medical history
also affect the likelihood of developing many disorders. These factors would be
discussed during a consultation with a doctor or genetic counselor, but in many cases
they are not addressed when using at-home genetic tests.
(https://ghr.nlm.nih.gov/primer/dtcgenetictesting/dtcrisksbenefits)